自闭症
临床试验
系统回顾
心理干预
肠道菌群
临床研究设计
医学
梅德林
失调
自闭症谱系障碍
重症监护医学
临床心理学
精神科
病理
免疫学
政治学
法学
作者
Olga Barba-Vila,Helena García‐Mieres,Belén Ramos
标识
DOI:10.1093/nutrit/nuae010
摘要
Abstract Context It is hypothesized that gut dysbiosis, a typical feature of patients with autism spectrum disorder (ASD), could be involved in the origin of this neurodevelopmental disorder. Therefore, the use of probiotics to restore gastrointestinal (GI) equilibrium might be a promising therapeutic strategy due to its capacity to balance the gut-brain axis and behavioral responses. Objective To summarize current knowledge on the use of probiotics to treat core clinical ASD symptoms and concomitant GI signs, compare the design of published studies with those of ongoing trials, assess the near future of this field, and provide recommendations for improving novel studies. Data sources The literature search was conducted in February 2020 and updated in March 2021, using a broad range of bibliographic and clinical trial–specific databases. Data extraction Data were extracted using a standardized form, and articles reporting on 28 clinical studies (already published or still ongoing) were included. The risk of bias in clinical studies was evaluated using the Cochrane Collaboration Risk of Bias Assessment tool for randomized trials and the Risk of Bias in Nonrandomized Studies–Interventions tool for nonrandomized trials. Results The results suggest that probiotics improve ASD-like social deficits, GI symptoms, and gut microbiota profile. However, inconsistencies among studies and their methodological limitations make it difficult to draw any conclusions regarding the efficacy of probiotics in ASD. This review provides specific suggestions for future research to improve the quality of the studies. Conclusions Although ongoing studies have improved designs, the available knowledge does not permit solid conclusions to be made regarding the efficacy of probiotics in ameliorating the symptoms (psychiatric and/or GI) associated with ASD. Thus, more high-quality research and new approaches are needed to design effective probiotic strategies for ASD.
科研通智能强力驱动
Strongly Powered by AbleSci AI